<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <?epub May-6-2014?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4086095</article-id>
    <article-id pub-id-type="pmid">24803671</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gku404</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PEP-SiteFinder: a tool for the blind identification of peptide
                    binding sites on protein surfaces</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Saladin</surname>
          <given-names>Adrien</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="AFF2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Rey</surname>
          <given-names>Julien</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="AFF2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="AFF3">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Thévenet</surname>
          <given-names>Pierre</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="AFF2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zacharias</surname>
          <given-names>Martin</given-names>
        </name>
        <xref ref-type="aff" rid="AFF4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Moroy</surname>
          <given-names>Gautier</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="AFF2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tufféry</surname>
          <given-names>Pierre</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="AFF2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="AFF3">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="COR1">*</xref>
      </contrib>
      <aff id="AFF1"><label>1</label>INSERM U973, MTi, F-75205 Paris, France</aff>
      <aff id="AFF2"><label>2</label>Université Paris Diderot, Sorbonne Paris
                    Cité, F-75205 Paris, France</aff>
      <aff id="AFF3"><label>3</label>Ressource Parisienne en Bioinformatique Structurale,
                    F-75205 Paris, France</aff>
      <aff id="AFF4"><label>4</label>Technische Universität München 80333
                    München, Germany</aff>
    </contrib-group>
    <author-notes>
      <corresp id="COR1"><label>*</label>To whom correspondence should be addressed. Tel:
                    +331 57278374; Fax: +331 57278372; Email:
                        <email>pierre.tuffery@univ-paris-diderot.fr</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>7</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>06</day>
      <month>5</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>06</day>
      <month>5</month>
      <year>2014</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>42</volume>
    <issue>Web Server issue</issue>
    <fpage>W221</fpage>
    <lpage>W226</lpage>
    <history>
      <date date-type="accepted">
        <day>25</day>
        <month>4</month>
        <year>2014</year>
      </date>
      <date date-type="rev-recd">
        <day>18</day>
        <month>4</month>
        <year>2014</year>
      </date>
      <date date-type="received">
        <day>07</day>
        <month>3</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2014. Published by Oxford University
                    Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2014</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/3.0/">
        <license-p>This is an Open Access article distributed under the terms of the
                        Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</uri>), which permits
                        unrestricted reuse, distribution, and reproduction in any medium, provided
                        the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="gku404.pdf"/>
    <abstract>
      <p>Peptide–protein interactions are important to many processes of life,
                    particularly for signal transmission or regulatory mechanisms. When no
                    information is known about the interaction between a protein and a peptide, it
                    is of interest to propose candidate sites of interaction at the protein surface,
                    to assist the design of biological experiments to probe the interaction, or to
                    serve as a starting point for more focused <italic>in silico</italic>
                    approaches. PEP-SiteFinder is a tool that will, given the structure of a protein
                    and the sequence of a peptide, identify protein residues predicted to be at
                    peptide–protein interface. PEP-SiteFinder relies on the 3D <italic>de
                        novo</italic> generation of peptide conformations given its sequence. These
                    conformations then undergo a fast blind rigid docking on the complete protein
                    surface, and we have found, as the result of a benchmark over 41 complexes, that
                    the best poses overlap to some extent the experimental patch of interaction for
                    close to 90% complexes. In addition, PEP-SiteFinder also returns a propensity
                    index we have found informative about the confidence of the prediction. The
                    PEP-SiteFinder web server is available at <ext-link ext-link-type="uri" xlink:href="http://bioserv.rpbs.univ-paris-diderot.fr/PEP-SiteFinder">http://bioserv.rpbs.univ-paris-diderot.fr/PEP-SiteFinder</ext-link>.</p>
    </abstract>
    <counts>
      <page-count count="6"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>1 July 2014</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Peptide–protein interactions are natural events of life, involving several
                well-known peptide categories such as hormones, peptides of the central nervous
                system (<xref rid="B1" ref-type="bibr">1</xref>), venom peptides (<xref rid="B2" ref-type="bibr">2</xref>), to cite some. In the recent years,
                peptide–protein interactions have also found an interest in studies
                targeting protein–protein interactions. For instance,
                protein–protein interactions can be mediated by short linear peptides that
                are present in disordered regions of proteins partners (<xref rid="B3" ref-type="bibr">3</xref>). There is also a large interest in the design of
                peptides extracted from structures to mimic protein epitopes in a therapeutic
                perspective (<xref rid="B4" ref-type="bibr">4</xref>), or to design peptide ligands
                from protein–protein complexes (<xref rid="B5" ref-type="bibr">5</xref>). In
                a general manner, peptides have, in the recent years, had a renewed interest as
                candidate therapeutics (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>).</p>
    <p>Present <italic>in silico</italic> approaches to assist the functional
                characterization of peptide–protein interactions can however be largely
                improved (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B8" ref-type="bibr">8</xref>). Several docking approaches have been developed to predict how a
                peptide and a protein interact. However, for a majority of these methods, such as
                DynaDock (<xref rid="B9" ref-type="bibr">9</xref>), Rosetta FlexPepDock refinement
                    (<xref rid="B10" ref-type="bibr">10</xref>), Rosetta FlexPepDock <italic>ab
                    initio</italic> (<xref rid="B11" ref-type="bibr">11</xref>), or PepCrawler
                    (<xref rid="B12" ref-type="bibr">12</xref>), the optimization of peptide
                conformation is only performed in the known binding site. Even the recent HADDOCK
                peptide docking protocol (<xref rid="B13" ref-type="bibr">13</xref>) also requires,
                to be successful, that the initial position of the peptide is within 5 Å
                from the peptide in the crystal structures of the complexes. Finally and noteworthy,
                probably due to large computational costs, only two web servers are currently
                available for local refinement of a peptide docked into the binding site:
                FlexPepDock (<xref rid="B14" ref-type="bibr">14</xref>) and PepCrawler (<xref rid="B12" ref-type="bibr">12</xref>). </p>
    <p>When the binding site is not known, a search on the whole protein
                surface—global docking or blind docking—must be performed. A
                classical docking program like AutoDock, designed for the small molecules docking,
                has been shown efficient for short peptides, such as four residues (<xref rid="B15" ref-type="bibr">15</xref>) or seven residues (<xref rid="B16" ref-type="bibr">16</xref>). For longer peptides, specific approaches have been developed.
                Dagliyan <italic>et al</italic>. (<xref rid="B17" ref-type="bibr">17</xref>) have
                shown the relevance of replica exchange all-atom discrete molecular dynamics
                simulations to identify correctly the peptide-binding sites. Verschueren <italic>et
                    al</italic>. have proposed a protocol to generate models of a peptide at the
                protein surface, using backbone fragments from the BriX database (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>). This
                method has been applied, successfully in most cases, on a dataset of 11 unbound
                complexes involving peptides of size up to 13 amino acids, and a dataset of 26 bound
                tetrapeptide-PDZ complexes. Although these programs have demonstrated their ability
                to carry out blind docking for short peptides, to the best of our knowledge, no web
                server is currently available.</p>
    <p>Instead of performing peptide docking, PepSite (<xref rid="B20" ref-type="bibr">20</xref>) aims at predicting the binding site for peptide on the whole protein
                surface, without returning a complete peptide structure. It is based on spatial
                position specific scoring matrices (S-PSSMs) for each of the 20 standard residues
                and three phosphorylated variants. The predicted binding sites for each amino acid
                are combined with the distance constraints according to the peptide sequence to
                identify potential binding site for the complete peptide. An online tool is
                available for an updated version of PepSite (<xref rid="B21" ref-type="bibr">21</xref>). It accepts peptides with a maximal size of 10 amino acids. Very
                recently, PeptiMap, an approach adapting a small molecule hot spot identification
                protocol to the identification of peptide binding site has been proposed (<xref rid="B22" ref-type="bibr">22</xref>). It has been calibrated on a subset of 21
                peptide–protein complexes from PeptiDB and validated using a set of nine
                complexes. It was possible to identify the binding site for 19 and seven of these 21
                and nine cases, respectively. It is so far not available online.</p>
    <p>Here, we present PEP-SiteFinder, a new tool to identify the peptide-binding site
                without any knowledge of the potential interaction site. PEP-SiteFinder combines the
                3D <italic>de novo</italic> prediction of the peptide structure and the blind
                docking of peptide predicted conformations using a coarse grained representation. It
                accepts peptides from four to 36 amino acids. We assess its performance on a third
                party collection of peptide–protein complexes using the conformation of the
                unbound protein. We show that PEP-SiteFinder is able to identify relevant
                information even in cases undergoing conformational changes upon peptide binding.
                Unlike previous tools, PEP-SiteFinder also quantifies the propensity of protein
                residues to be at the peptide interface, which we find to correlate with the
                experimental observations.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Dataset</title>
      <p>To benchmark the performance of PEP-SiteFinder, we have used the PeptiDB dataset
                        (<xref rid="B23" ref-type="bibr">23</xref>). PeptiDB consists in 103
                    high-resolution peptide–protein complexes (holo conformation), resolved
                    using X-ray diffraction, with a resolution lower than 2 Å and presenting
                    no sequence identity between two protein monomers more than 70%. The bound
                    peptides have a size between five and 15 amino acids. The protein uncomplexed
                    (apo) conformation is available for 78 complexes and PeptiDB defines a core set
                    of 41 non-redundant complexes, an additional set of 26 complexes structurally
                    redundant with the core set according to Class-Architecture-Topology-Homologous
                    superfamily (CATH) structural classification (<xref rid="B24" ref-type="bibr">24</xref>), and a subset of 11 complexes for which large conformational
                    changes occur. Details about the dataset are provided in the Supplementary data.
                    We have performed our tests using the apo conformations and the peptide
                    sequences as input of PEP-SiteFinder and PepSite, and compared the residues
                    predicted in interaction with those at peptide–protein interface in the
                    complexes.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Protein–peptide interactions</title>
      <p>Figure <xref ref-type="fig" rid="F1">1</xref> depicts a flowchart of
                    PEP-SiteFinder. It consists in three main steps detailed hereafter.</p>
      <fig id="F1" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>PEP-SiteFinder flowchart.</p>
        </caption>
        <graphic xlink:href="gku404fig1"/>
      </fig>
      <sec id="SEC2-2-1">
        <title>Peptide 3D conformation generation</title>
        <p>A first step is the prediction of an ensemble of conformations from the
                        peptide sequence, independently of the protein. It is achieved using
                        PEP-FOLD (<xref rid="B25" ref-type="bibr">25–27</xref>). PEP-FOLD
                        relies on the concept of structural alphabets, a generalization of the
                        concept of secondary structure extending the number of states from three
                        (helix, strand, coil) up to 27 in our case. The states describe the
                        conformation of fragments of four amino acids, which corresponds to the
                        smallest peptide size PEP-SiteFinder can process. Given a peptide sequence,
                        the probabilities of the states are predicted at each position of the
                        peptide, and the states associated with the largest probabilities are
                        selected. The 3D assembly is then performed from the prototype fragments
                        associated with each of the states, using the coarse grained force field
                        sOPEP (<xref rid="B26" ref-type="bibr">26</xref>). PEP-FOLD has been shown
                        to be efficient for the <italic>de novo</italic> generation of peptides in
                        solution up to 36 amino acids, which corresponds to the present upper
                        peptide size for PEP-SiteFinder. For such sizes, the lowest energy
                        conformations deviate, on average by 2.5 Å from the Nuclear
                        magneticresonance (NMR) rigid cores (<xref rid="B27" ref-type="bibr">27</xref>).</p>
        <p>Since peptides are known to possibly undergo conformational changes upon
                        protein binding, it can be penalizing to consider only the lowest energy
                        conformation. For PEP-SiteFinder, we use a modified version of PEP-FOLD that
                        allows to sample the sub-optimal conformations. This version revisits the 3D
                        generation procedure to return, given a peptide sequence, a diverse
                        collection of conformations instead of searching for the lowest energy
                        conformation. In practice, for each peptide, we generate 200 suboptimal
                        conformations that are then clusterized. The centroids of up to the 20
                        clusters of lowest energy are selected for the docking step.</p>
      </sec>
      <sec id="SEC2-2-2">
        <title>Peptide–protein blind rigid docking</title>
        <p>For each generated peptide structure, systematic rigid docking is performed
                        using the ATTRACT docking protocol (<xref rid="B28" ref-type="bibr">28</xref>) using the version 2 of the ATTRACT forcefield (<xref rid="B29" ref-type="bibr">29</xref>) as implemented in the PTools
                        library (<xref rid="B30" ref-type="bibr">30</xref>). The ATTRACT docking
                        protocol has been described previously (<xref rid="B28" ref-type="bibr">28</xref>) and only a brief description of the method is given
                        here.</p>
        <p>The first step of the method is the translation of the protein and the
                        peptide into a reduced coarse-grained representation. In this second version
                        of the ATTRACT forcefield, all atoms from the backbone are kept while side
                        chains are represented by up to two pseudo-atoms. The energy function is the
                        sum of two contributions, the electrostatic energy and a pairwise soft
                        Lennard-Jones potential (<xref rid="B29" ref-type="bibr">29</xref>).</p>
        <p>After this reduction step, starting points are regularly positioned around
                        the protein, at a distance of two times the radius of the peptide from the
                        protein surface and about 10 Å from each other. For each starting
                        point, 260 peptide orientations are generated and an energy minimization is
                        performed, allowing the peptide to move only in translational and rotational
                        degrees of freedom (rigid-body docking). Since all starting positions are
                        independent, this step is performed in parallel on our cluster on up to
                        (arbitrarily) 180 cores, allowing us to perform a blind docking simulation
                        usually in less than a minute for most targets. Minimized structures are
                        then ranked by energy after merging the results from all calculating
                        processes.</p>
        <p>At the end of the process, up to 20 systematic rigid docking simulations have
                        been performed. Redundant solutions are filtered out by a fast clustering
                        procedure. Poses are ranked by energy and are picked one after another
                        starting with the ligand with the lowest energy. If a ligand has a
                        Root-Mean-Square Deviation (RMSD) of less than 1 Å with respect to
                        previously found clusters this ligand is considered to be redundant and is
                        discarded. Otherwise this ligand is considered to represent a new cluster.
                        To keep the algorithm in O(<italic>n</italic>) with respect to the number of
                        poses, only the latest 50 clusters are compared to a new ligand.</p>
        <p>After this clustering step, the best solutions from each docking simulation
                        are aggregated and ranked by their energy of interaction with the
                        protein.</p>
      </sec>
      <sec id="SEC2-2-3">
        <title>Residues at peptide–protein interface</title>
        <p>A last step consists in assessing the propensities of protein residues to
                        interact with the peptide. These are defined over the 50 best poses ranked
                        according to the ATTRACT2 force field. For each pose, protein residues at
                        the peptide interface are defined as the residues having at least one heavy
                        atom at a distance of less than 5 Å of any peptide heavy atom. The
                        propensity of a residue <italic>r</italic> is then calculated as the
                        fraction of times it has been at the peptide–protein interface:
                                <inline-formula><tex-math id="M1">\documentclass[12pt]{minimal}
                                \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}
                                \usepackage{amssymb} \usepackage{amsbsy} \usepackage{upgreek}
                                \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt}
                                \begin{document} }{}$p_r = 100 \sum _{i=1}^{50} p_r^i /
                                50$\end{document}</tex-math></inline-formula><inline-formula><tex-math id="M2">\documentclass[12pt]{minimal} \usepackage{amsmath}
                                \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb}
                                \usepackage{amsbsy} \usepackage{upgreek} \usepackage{mathrsfs}
                                \setlength{\oddsidemargin}{-69pt} \begin{document} }{}$p_r = 100
                                \sum _{i=1}^{50} p_r^i /
                            50$\end{document}</tex-math></inline-formula> where <italic>i</italic>
                        corresponds to the 50 best poses and <inline-formula><tex-math id="M3">\documentclass[12pt]{minimal} \usepackage{amsmath}
                                \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb}
                                \usepackage{amsbsy} \usepackage{upgreek} \usepackage{mathrsfs}
                                \setlength{\oddsidemargin}{-69pt} \begin{document}
                                }{}$p_r^i$\end{document}</tex-math></inline-formula><inline-formula><tex-math id="M4">\documentclass[12pt]{minimal} \usepackage{amsmath}
                                \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb}
                                \usepackage{amsbsy} \usepackage{upgreek} \usepackage{mathrsfs}
                                \setlength{\oddsidemargin}{-69pt} \begin{document}
                                }{}$p_r^i$\end{document}</tex-math></inline-formula> is one of (0,
                        1), 1 meaning the residue <italic>r</italic> is at peptide–protein
                        interface for pose <italic>i</italic>.</p>
      </sec>
    </sec>
    <sec id="SEC2-3">
      <title>Comparison with PepSite</title>
      <p>To compare our results with those of PepSite (<xref rid="B21" ref-type="bibr">21</xref>), we have submitted the complete collection of peptides to the
                    PepSite2 web server. Results were returned for only the subset of peptides of
                    size less than 11 amino acids. To assess the residues predicted at
                    protein–peptide interface, we have proceeded in a similar way than for
                    the calculation of residue propensities to be at the interface. However, since
                    PepSite only returns one centroid per residue, and since we could not find a
                    clear equivalence in terms of atomic position of a residue, we have, in order to
                    keep the comparison as fair as possible, identified the protein residue
                    contacted considering only the peptide alpha-carbons for PEP-SiteFinder and the
                    centroids for PepSite, using a distance threshold or 6.5 and 10 Å,
                    respectively. Only protein heavy atoms have been considered.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Comparison with a pocket binding site identification method</title>
      <p>We have used the fpocket (<xref rid="B31" ref-type="bibr">31</xref>) pocket
                    detection software on all protein, using the apo conformations, to identify
                    small compound binding pockets. Since fpocket has been reported to identify the
                    pockets in interaction with small ligands at a success rate over 90% in the best
                    three pockets, we have estimated the fraction of protein residues interacting
                    with the ligand and belonging to the three top pockets identified.</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>WEB INTERFACE</title>
    <sec id="SEC3-1">
      <title>Input</title>
      <p>PEP-SiteFinder takes as an input a protein structure (PDB format) and a peptide
                    sequence. The size of the input sequence must be between four and 36 amino acids
                    (see ‘Materials and Methods’ section). There is in theory no
                    limit about the protein size, but proteins including non polypeptidic chains
                    (e.g. nucleic acids) are presently not accepted. Also note that the docking
                    process discards all the hetero atoms of the input file. To test the service,
                    the user can run a pre-configured test (GRIP1 PDZ domain in complex with liprin
                    C-terminal peptide in interaction with the 8-mer peptide
                    ‘ATVRTYSC’ which corresponds to the chain D of 1N7F). Even
                    though both PEP-FOLD and rigid docking steps are rather fast, a typical run of
                    PEP-SiteFinder requires up to 30 min and more, depending on the size of the
                    protein, the number of peptide conformations generated using PEP-FOLD and the
                    server load. Information about the job progress is periodically updated.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Output</title>
      <p>PEP-SiteFinder provides several outputs. The first consists in an interactive
                    page allowing to browse the 3D structure of the best complexes generated, to
                    identify the protein residues close to the different peptide poses sorted
                    according to their ATTRACT2 scores, or the protein residues having large
                    predicted propensities to be at peptide–protein interface. This facility
                    depends on Jmol (<xref rid="B32" ref-type="bibr">32</xref>) and thus requires a
                    Java plug-in to be installed. The user can also download the PDB files
                    corresponding to the protein with the interaction propensities set in the
                    temperature factor field (columns 61–66), and to the peptide poses,
                    organized as a multiple model PDB, together with a PyMOL script to drive the
                    off-web analysis of the results. Finally, a file listing the propensities per
                    residue is also returned.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC4">
    <title>RESULTS</title>
    <sec id="SEC4-1">
      <title>Example application on the PriA deoxyribonucleic acid (DNA)
                    helicase—ssDNA-binding proteins (SSB) peptide interaction</title>
      <p>We illustrate the interest of PEP-SiteFinder in the context of the Critical
                    Assessment of Predicted Interactions (CAPRI) contest (<xref rid="B33" ref-type="bibr">33</xref>) target 66. Its object was the complex between the
                    PriA DNA helicase and a SSB peptide. Before the completion of replication,
                    collisions between cellular DNA replication machinery (replisomes) and damaged
                    DNA or immovable protein complexes can occur and dissociate replisomes. This
                    potentially lethal problem is resolved by the PriA DNA helicase which identifies
                    replication forks via structure-specific DNA binding and interactions with
                    fork-associated ssDNA-binding proteins (SSBs). The characterization of the
                    interaction between PriA and SSBs is thus of particular interest. However, the
                    mechanism by which PriA binds replication fork DNA and coordinates subsequent
                    replication restart reactions have remained unclear until high resolution
                    structural information was obtained by crystallography (<xref rid="B34" ref-type="bibr">34</xref>). Given the sequence of a SSB peptide and the
                    structure of PriA DNA helicase, Figure <xref ref-type="fig" rid="F2">2</xref>
                    shows the 10 best poses of a SSB peptide of sequence
                    ‘WMDFDDDIPF’ (shown in green) bound to PriA Helicase returned by
                    PEP-SiteFinder, as could be explored in the PEP-SiteFinder result page. The
                    colors of residue propensities to interact vary from red (large
                    propensities—100) to blue (low propensities—0). The best spot
                    returned corresponds, for this complex, to the actual interaction site.</p>
      <fig id="F2" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>PEP-SiteFinder interactive page for the exploration of the best poses for
                            the PriA helicase—SSB peptide complex (PDB code: 4NL8). Protein
                            residues are colored according to their predicted propensities, from
                            blue (0) to red (100).</p>
        </caption>
        <graphic xlink:href="gku404fig2"/>
      </fig>
    </sec>
    <sec id="SEC4-2">
      <title>Tests on the PeptiDB dataset</title>
      <p>We have assessed the performance of PEP-SiteFinder over the complete PeptiDB
                    collection (see Supplementary data), by searching on the surface of the unbound
                    protein conformation the experimental peptide binding site. We first focus on
                    the results obtained for the PeptiDB core subset of 41 complexes, and we first
                    analyze how the 10 best poses generated by PEP-SiteFinder target the actual
                    interaction patch (summarized Figure <xref ref-type="fig" rid="F3">3A</xref>). A
                    major result is that the 10 best poses generated by PEP-Sitefinder fail to match
                    any of the protein residues interacting with peptide for only four cases, i.e.
                    for only 10% of the cases. For all other complexes, the 10 best poses generated
                    by PEP-SiteFinder return, to different extents, relevant information about
                    candidate residues at peptide–protein interface. Actually, piling up the
                    analyses of the 10 best poses allows to identify &gt;50% of the interacting
                    residues for as much as 71% of the complexes. This strongly suggests, firstly,
                    that the best poses, even starting with <italic>de novo</italic> predicted
                    conformations can target the right protein patch and secondly, that piling up
                    the best poses can have added value. We have also looked at the impact of the
                    peptide conformation on the correct identification of the binding site. Overall,
                    we find that the 20 conformations generated by PEP-FOLD approximate the
                    conformation of the peptide in the complex at 3.5 Å RMSD, on average.
                    The corresponding value is of 3.4 Å for the peptides of the 10 best
                    poses and no significant deviation was observed for targets for which
                    PEP-SiteFinder failed. This suggests that the quality of the PEP-FOLD
                    conformations is intrinsically sufficient for the blind identification of the
                    binding site, although the exact quantification of the minimal approximation to
                    allow it is the matter for further investigation.</p>
      <fig id="F3" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>PEP-SiteFinder (<bold>A</bold>) and PepSite (<bold>B</bold>) performance
                            over the PeptiDB core subset. Fraction of residues of the binding site
                            contacted by the 10 best poses. (<bold>C</bold>) Probability that a
                            residue is in the binding site (correct prediction) as a function of the
                            propensity. The error bars correspond to the standard deviation
                            estimated over five independent runs.</p>
        </caption>
        <graphic xlink:href="gku404fig3"/>
      </fig>
      <p>On the same data, PepSite returned results for only 29 complexes (peptide size
                    upper limit of 10 amino acids), and could not identify any residue in the
                    correct region for eight complexes, i.e. 27% of the cases. We also find that
                    PepSite could identify more than 50% of the interacting residues among the 10
                    best poses for 48%. This highlights the added value of the PEP-SiteFinder 3D
                    approach by comparison with a knowledge based approach such as PepSite. However,
                    PepSite and PEP-SiteFinder both fail, for only one target suggesting added value
                    could be found in a combination of the two approaches.</p>
      <p>Interestingly as well, we found that the top three pockets identified by a pocket
                    identification program such as fpocket do not correspond to the peptide binding
                    site for 11 cases. For all these cases, PEP-SiteFinder returned relevant
                    information. Supplementary Figure S<xref ref-type="fig" rid="F1">1</xref>
                    depicts one such case. Despite fpocket top three pockets match to some extent
                    the peptide binding site for four cases where PEP-SiteFinder fails, this
                    highlights the interest of a peptide-specific approach.</p>
      <p>Supplementary Figure <xref ref-type="fig" rid="F3">3C</xref> shows, as averaged
                    over five independent PEP-SiteFinder runs, that large propensity values are
                    associated with large probability values that the residues are located at the
                    peptide–protein interface. The observed probability that a residue is
                    actually at peptide–protein interface is of over 80% for propensity
                    values &gt;80%. Over all the 41 complexes, we find that the fraction of
                    cases for which it would be possible to identify a residue at the
                    peptide–protein interface considering the residue with the largest
                    propensity is of 56%, increasing up to 71 and 73% considering the five and 10
                    best propensities, respectively. Interestingly also, increasing the distance
                    cutoff to identify the residues contacted by the poses to 10 Å, the
                    corresponding fractions are of 73, 76 and 78% suggesting some of the residues
                    with the best propensities are in the vicinity of the binding site. However, we
                    recall that presently the propensities are estimated residue per residue, i.e.
                    not considering the proximity of the residue on the protein surface. To
                    summarize, our results show that the combined analysis of the best scored poses
                    and the propensities can be of great interest to identify candidate residues on
                    the protein surface.</p>
      <p>Finally, we briefly comment on the results obtained for PeptiDB complexes
                    annotated as undergoing large conformational changes and for which the peptide
                    binding site is accessible. Most often, the conformational changes correspond to
                    the conformational modification of one or several loops upon peptide binding.
                    Interestingly, we observe that PEP-SiteFinder is able to propose valuable
                    predictions for all such cases. In our understanding, the diversity of the
                    peptide conformation used by PEP-SiteFinder can accommodate such structural
                    differences. Two such examples are depicted in the Supplementary data. These few
                    cases also suggest that PEP-SiteFinder should be able to provide confident
                    prediction with low quality conformations such as could be built by homology
                    modeling, although this remains the subject for further investigation.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC5">
    <title>CONCLUSION</title>
    <p>PEP-SiteFinder is a tool to predict peptide-binding sites given a protein structure
                and a peptide sequence. Its strategy is to generate 3D conformations of the peptide
                from its sequence and then to use a rigid docking approach that scans the complete
                protein surface to extract information about the protein residues likely to be
                located at peptide–protein interface. Though PEP-SiteFinder relies on
                approximate peptide conformations, our results show that such an approach is
                effective, and performs, on average, better than a knowledge based approach such as
                PepSite. A counterpart of such strategy is that it is much more computer intensive.
                Nevertheless, being much slower than PepSite, it remains fast enough for a 3D
                approach, typical execution times being on the order of 30 min to 1 h. Several
                directions can be considered to improve PEP-SiteFinder, ranging from the
                identification of the patches of protein residues with large propensities, to
                revisiting the generation of the 3D conformations or enhancing complex scoring.
                However PEP-SiteFinder, in its present version, already provides useful information
                to guide mutagenesis experiments to probe peptide–protein interactions or to
                provide starting points for more accurate peptide–protein docking
                experiments.</p>
    <sec id="SEC6">
      <title>ACCESSION NUMBER</title>
      <p>PDB ID: 4NL8.</p>
    </sec>
    <sec id="SEC6-1">
      <title>SUPPLEMENTARY DATA</title>
      <p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gku404/-/DC1">Supplementary Data</ext-link> are available at NAR Online.</p>
    </sec>
    <sec id="SEC6-2">
      <title>FUNDING</title>
      <p>French IA bioinformatics BipBip grant; INSERM UMR-S 973; Ressource Parisienne en
                    Bioinformatique Structurale. Funding for open access charge: INSERM UMR-S
                    973.</p>
      <p><italic>Conflict of interest statement</italic>. None declared.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="PMC_1" content-type="local-data">
      <caption>
        <title>Supplementary Data</title>
      </caption>
      <media mimetype="text" mime-subtype="html" xlink:href="supp_42_W1_W221__index.html"/>
      <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_gku404_nar-00650-web-b-2014-File008.pdf"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Malavolta</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cabral</surname>
            <given-names>F.R.</given-names>
          </name>
        </person-group>
        <article-title>Peptides: important tools for the treatment of central nervous
                        system disorders</article-title>
        <source>Neuropeptides</source>
        <year>2011</year>
        <volume>45</volume>
        <fpage>309</fpage>
        <lpage>316</lpage>
        <pub-id pub-id-type="pmid">21477861</pub-id>
      </element-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vetter</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>J.L.</given-names>
          </name>
          <name>
            <surname>Rash</surname>
            <given-names>L.D.</given-names>
          </name>
          <name>
            <surname>Anangi</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Mobli</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Alewood</surname>
            <given-names>P.F.</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>King</surname>
            <given-names>G.F.</given-names>
          </name>
        </person-group>
        <article-title>Venomics: a new paradigm for natural products-based drug
                        discovery</article-title>
        <source>Amino Acids</source>
        <year>2011</year>
        <volume>40</volume>
        <fpage>15</fpage>
        <lpage>28</lpage>
        <pub-id pub-id-type="pmid">20177945</pub-id>
      </element-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Petsalaki</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>R.B.</given-names>
          </name>
        </person-group>
        <article-title>Peptide-mediated interactions in biological systems: new
                        discoveries and applications</article-title>
        <source>Curr. Opin. Biotech.</source>
        <year>2008</year>
        <volume>19</volume>
        <fpage>344</fpage>
        <lpage>350</lpage>
        <pub-id pub-id-type="pmid">18602004</pub-id>
      </element-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robinson</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Demarco</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gombert</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Moehle</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Obrecht</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>The design, structures and therapeutic potential of protein
                        epitope mimetics</article-title>
        <source>Drug Discov. Today</source>
        <year>2008</year>
        <volume>13</volume>
        <fpage>944</fpage>
        <lpage>951</lpage>
        <pub-id pub-id-type="pmid">18725320</pub-id>
      </element-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanhee</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>van der Sloot</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Verschueren</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Schymkowitz</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Computational design of peptide ligands</article-title>
        <source>Trends. Biotechnol.</source>
        <year>2011</year>
        <volume>29</volume>
        <fpage>231</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="pmid">21316780</pub-id>
      </element-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vlieghe</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lisowski</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Khrestchatisky</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Synthetic therapeutic peptides: science and
                        market</article-title>
        <source>Drug Discov. Today</source>
        <year>2010</year>
        <volume>15</volume>
        <fpage>40</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="pmid">19879957</pub-id>
      </element-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boyle</surname>
            <given-names>A.L.</given-names>
          </name>
          <name>
            <surname>Woolfson</surname>
            <given-names>D.N.</given-names>
          </name>
        </person-group>
        <article-title>De novo designed peptides for biological
                        applications</article-title>
        <source>Chem. Soc. Rev.</source>
        <year>2011</year>
        <volume>40</volume>
        <fpage>4295</fpage>
        <lpage>4306</lpage>
        <pub-id pub-id-type="pmid">21373694</pub-id>
      </element-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>London</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Raveh</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
        </person-group>
        <article-title>Peptide docking and structure-based characterization of peptide
                        binding: from knowledge to know-how</article-title>
        <source>Curr. Opin. Struct. Biol.</source>
        <year>2013</year>
        <volume>23</volume>
        <fpage>894</fpage>
        <lpage>902</lpage>
        <pub-id pub-id-type="pmid">24138780</pub-id>
      </element-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Antes</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>DynaDock: A new molecular dynamics-based algorithm for
                        protein-peptide docking including receptor flexibility</article-title>
        <source>Proteins</source>
        <year>2010</year>
        <volume>78</volume>
        <fpage>1084</fpage>
        <lpage>1104</lpage>
        <pub-id pub-id-type="pmid">20017216</pub-id>
      </element-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raveh</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>London</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
        </person-group>
        <article-title>Sub-angstrom modeling of complexes between flexible peptides and
                        globular proteins</article-title>
        <source>Proteins</source>
        <year>2010</year>
        <volume>78</volume>
        <fpage>2029</fpage>
        <lpage>2040</lpage>
        <pub-id pub-id-type="pmid">20455260</pub-id>
      </element-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raveh</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>London</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
        </person-group>
        <article-title>Rosetta FlexPepDock ab-initio: simultaneous folding, docking and
                        refinement of peptides onto their receptors</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e18934</fpage>
        <pub-id pub-id-type="pmid">21572516</pub-id>
      </element-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Donsky</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Wolfson</surname>
            <given-names>H.J.</given-names>
          </name>
        </person-group>
        <article-title>PepCrawler: a fast RRT- based algorithm for high-resolution
                        refinement and binding affinity estimation of peptide
                        inhibitors</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>2836</fpage>
        <lpage>2842</lpage>
        <pub-id pub-id-type="pmid">21880702</pub-id>
      </element-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trellet</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Melquiond</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bonvin</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>A unified conformational selection and induced fit approach to
                        protein-peptide docking</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e58769</fpage>
        <pub-id pub-id-type="pmid">23516555</pub-id>
      </element-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>London</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Raveh</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Fathi</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
        </person-group>
        <article-title>Rosetta FlexPepDock web server-high resolution modeling of
                        peptide-protein interactions</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>W249</fpage>
        <lpage>W253</lpage>
        <pub-id pub-id-type="pmid">21622962</pub-id>
      </element-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hetényi</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>van der Spoel</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Efficient docking of peptides to proteins without prior knowledge
                        of the binding site</article-title>
        <source>Protein Sci.</source>
        <year>2002</year>
        <volume>11</volume>
        <fpage>1729</fpage>
        <lpage>1737</lpage>
        <pub-id pub-id-type="pmid">12070326</pub-id>
      </element-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prasad</surname>
            <given-names>P.A.</given-names>
          </name>
          <name>
            <surname>Gautham</surname>
            <given-names>N.</given-names>
          </name>
        </person-group>
        <article-title>A new peptide docking strategy using a mean field technique with
                        mutually orthogonal latin square sampling</article-title>
        <source>J. Comput. Aid. Mol. Des.</source>
        <year>2008</year>
        <volume>22</volume>
        <fpage>815</fpage>
        <lpage>829</lpage>
      </element-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dagliyan</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Proctor</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>D’Auria</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Dokholyan</surname>
            <given-names>N.V.</given-names>
          </name>
        </person-group>
        <article-title>Structural and dynamic determinants of protein-peptide
                        recognition</article-title>
        <source>Structure</source>
        <year>2011</year>
        <volume>19</volume>
        <fpage>1837</fpage>
        <lpage>1845</lpage>
        <pub-id pub-id-type="pmid">22153506</pub-id>
      </element-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanhee</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Verschueren</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Baeten</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Stricher</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Schymkowitz</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>BriX: a database of protein building blocks for structural
                        analysis, modeling and design</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D435</fpage>
        <lpage>D442</lpage>
        <pub-id pub-id-type="pmid">20972210</pub-id>
      </element-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verschueren</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Vanhee</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Schymkowitz</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Protein-peptide complex prediction through fragment interaction
                        patterns</article-title>
        <source>Structure</source>
        <year>2013</year>
        <volume>21</volume>
        <fpage>789</fpage>
        <lpage>797</lpage>
        <pub-id pub-id-type="pmid">23583037</pub-id>
      </element-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Petsalaki</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Stark</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Garca-Urdiales</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>R.B.</given-names>
          </name>
        </person-group>
        <article-title>Accurate prediction of peptide binding sites on protein
                        surfaces</article-title>
        <source>PLoS Comput. Biol.</source>
        <year>2009</year>
        <volume>5</volume>
        <fpage>e1000335</fpage>
        <pub-id pub-id-type="pmid">19325869</pub-id>
      </element-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trabuco</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>Lise</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Petsalaki</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>R.B.</given-names>
          </name>
        </person-group>
        <article-title>PepSite: prediction of peptide-binding sites from protein
                        surfaces</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>W423</fpage>
        <lpage>W427</lpage>
        <pub-id pub-id-type="pmid">22600738</pub-id>
      </element-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lavi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ngan</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Movshovitz-Attias</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Bohnuud</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Yueh</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Beglov</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Detection of peptide-binding sites on protein surfaces: the first
                        step toward the modeling and targeting of peptide-mediated
                        interactions</article-title>
        <source>Proteins</source>
        <year>2013</year>
        <volume>81</volume>
        <fpage>2096</fpage>
        <lpage>2105</lpage>
        <pub-id pub-id-type="pmid">24123488</pub-id>
      </element-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>London</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Movshovitz-Attias</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Schueler-Furman</surname>
            <given-names>O.</given-names>
          </name>
        </person-group>
        <article-title>The structural basis of peptide-protein binding
                        strategies</article-title>
        <source>Structure</source>
        <year>2010</year>
        <volume>18</volume>
        <fpage>188</fpage>
        <lpage>199</lpage>
        <pub-id pub-id-type="pmid">20159464</pub-id>
      </element-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Orengo</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Michie</surname>
            <given-names>A.D.</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>D.T.</given-names>
          </name>
          <name>
            <surname>Swindells</surname>
            <given-names>M.B.</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>J.M.</given-names>
          </name>
        </person-group>
        <article-title>CATH-a hierarchic classification of protein domain
                        structures</article-title>
        <source>Structure</source>
        <year>1997</year>
        <volume>5</volume>
        <fpage>1093</fpage>
        <lpage>1108</lpage>
        <pub-id pub-id-type="pmid">9309224</pub-id>
      </element-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maupetit</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Derreumaux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Tufféry</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>PEP-FOLD: an online resource for de novo peptide structure
                        prediction</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2009</year>
        <volume>37</volume>
        <fpage>W498</fpage>
        <lpage>W503</lpage>
        <pub-id pub-id-type="pmid">19433514</pub-id>
      </element-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maupetit</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Derreumaux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Tufféry</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>A fast method for large-scale de novo peptide and miniprotein
                        structure prediction</article-title>
        <source>J. Comput. Chem.</source>
        <year>2010</year>
        <volume>31</volume>
        <fpage>726</fpage>
        <lpage>738</lpage>
        <pub-id pub-id-type="pmid">19569182</pub-id>
      </element-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thévenet</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Maupetit</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Guyon</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Derreumaux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Tufféry</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>PEP-FOLD: an updated de novo structure prediction server for both
                        linear and disulfide bonded cyclic peptides</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>W288</fpage>
        <lpage>W293</lpage>
        <pub-id pub-id-type="pmid">22581768</pub-id>
      </element-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zacharias</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Protein-protein docking with a reduced protein model accounting
                        for side-chain flexibility</article-title>
        <source>Protein Sci.</source>
        <year>2003</year>
        <volume>12</volume>
        <fpage>1271</fpage>
        <lpage>1282</lpage>
        <pub-id pub-id-type="pmid">12761398</pub-id>
      </element-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fiorucci</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Zacharias</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Binding site prediction and improved scoring during flexible
                        protein-protein docking with ATTRACT</article-title>
        <source>Proteins</source>
        <year>2010</year>
        <volume>78</volume>
        <fpage>3131</fpage>
        <lpage>3139</lpage>
        <pub-id pub-id-type="pmid">20715290</pub-id>
      </element-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saladin</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Fiorucci</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Poulain</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Prévost</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Zacharias</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>PTools: an opensource molecular docking library</article-title>
        <source>BMC Struct. Biol.</source>
        <year>2009</year>
        <volume>9</volume>
        <fpage>27</fpage>
        <pub-id pub-id-type="pmid">19409097</pub-id>
      </element-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Guilloux</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Schmidtke</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Tuffery</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Fpocket: an open source platform for ligand pocket
                        detection</article-title>
        <source>BMC Bioinformatics</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>168</fpage>
        <pub-id pub-id-type="pmid">19486540</pub-id>
      </element-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanson</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Jmol—a paradigm shift in crystallographic
                        visualization</article-title>
        <source>J. Appl. Crystallogr.</source>
        <year>2010</year>
        <volume>43</volume>
        <fpage>1250</fpage>
        <lpage>1260</lpage>
      </element-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lensink</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Wodak</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Docking, scoring and affinity prediction in capri</article-title>
        <source>Proteins</source>
        <year>2013</year>
        <volume>81</volume>
        <fpage>2082</fpage>
        <lpage>2095</lpage>
        <pub-id pub-id-type="pmid">24115211</pub-id>
      </element-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bhattacharyya</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>George</surname>
            <given-names>N.P.</given-names>
          </name>
          <name>
            <surname>Thurmes</surname>
            <given-names>T.M.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jani</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Wessel</surname>
            <given-names>S.R.</given-names>
          </name>
          <name>
            <surname>Sandler</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Ha</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Keck</surname>
            <given-names>J.L.</given-names>
          </name>
        </person-group>
        <article-title>Structural mechanisms of PriA-mediated DNA replication
                        restart</article-title>
        <source>Proc. Natl. Acad. Sci. U.S.A.</source>
        <year>2014</year>
        <volume>111</volume>
        <fpage>1373</fpage>
        <lpage>1378</lpage>
        <pub-id pub-id-type="pmid">24379377</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
